Abstract:Objective To investigate the clinical characteristics and strategies of early stage antibody-mediated rejection after renal transplantation.Method The clinical data of early stage AMR of 3 cases of renal transplantation,and 1 case of pancreas transplantation after renal transplantation were retrospectively analyzed.(1) The case 1 was diagnosed as having early severe acute AMR.Serum creatinine was increased,urine volume rapidly reduced,the blood flow of transplanted kidney reduced on the postoperative day 8;the positive rate of panel reactive antibody (PRA) class Ⅰ and Ⅱ was 74.6％,and 2.7％ respectively on the postoperative day 12.Biopsy showed widely ischemia and local bleeding in transplanted kidney and DSA showed anti-B62 mean fluorescence intensity (MFI) increased to 6800 on the postoperative day 14.(2) The case 2 was diagnosed as having early mild acute AMR.The positive rate of PRA class [and Ⅱ was 65.6％ and 78.9％ respectively.DSA Ⅰ was positive,anti A11 MFI was 3059,and DSA Ⅱ was negative on the postoperative day 13.Biopsy showed mild ischemia reperfusion injury in transplanted kidney on the postoperative day 21.(3) The case 3 was diagnosed as having early severe chronic AMR,and the recipient received pancreas transplantation 1 year after kidney transplantation.Eight months after pancreas transplantation,DSA for pancreas donor was detectable,anti A2 MFI was 7514,anti B46 MFI was 3 159 and anti DQ7 MFI was 1 503.(4) The case 4 was diagnosed as having early mixed rejection.Serum creatinine was elevated on the postoperative day 8;PRA testing showed that the positive rate of class Ⅰ and Ⅱ was 3％ and 70％ respectively,DSA was positive,and anti DR16 MFI was 15 170 on the postoperative day 14;transplanted kidney biopsy showed acute mixed rejection on the postoperative day 16.Result Case 1 and case 3 were not diagnosed and treated in time and graft loss developed.Case 2 and case 4 were functionally recovered after combined treatment of plasmapheresis,IVIG and bortezomib.Conclusion Diagnosis of antibody-mediated rejection is based on transplant graft dysfunction,positive DSA and graft biopsy.Early diagnosis,early treatment and combined therapy can improve the curative rate of AMR.

Protective role of triptolide in a rat model of antibody-mediated rejection in kidney transplantation

Triptolide Inhibits Donor-Specific Antibody Production and Attenuates Mixed Antibody-Mediated Renal Allograft Injury.

Triptolide Attenuates Transplant Vasculopathy Through Multiple Pathways

In Vitro and in Vivo Immunomodulatory Effects of Triptolide Administered in Acute Kidney Allograft Rejection

Mouse Model Established by Early Renal Transplantation after Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection.

Ex Vivo Anchored PD‐L1 Functionally Prevent in Vivo Renal Allograft Rejection

Helper T Cell (CD4 + ) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity

Bortezomib alleviates antibody-mediated rejection in kidney transplantation by facilitating Atg5 expression

Prevention of kidney allograft rejection in rat by immune tolerance i nduction

Characteristic of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation

Immune Tolerance Induced by Immature Dendritic Cells and Bone Marrow Transplantation in Rat Renal Allogeneic Graft Model and Its Mechanisms

Triptolide-conditioned Dendritic Cells Induce Allospecific T-cell Regulation and Prolong Renal Graft Survival.

Prevention of chronic renal allograft rejection by soluble CD83

In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells

Triptolide Reduces the Required Dose of Tacrolimus by Attenuating Inflammation, Enhancing Immunosuppression, and Increasing Donor Chimerism in a Heterotopic Hindlimb Transplantation Model.

The Subacute Renal Toxicity of Triptolide in Wistar Rats

Iguratimod Attenuates Macrophage Polarization and Antibody-Mediated Rejection After Renal Transplant by Regulating KLF4

Clinical Characteristics and Strategies of Early Stage Antibody-Mediated Rejection after Renal Transplantation

Induction of Chronic Renal Allograft Injury by Injection of a Monoclonal Antibody Against a Donor MHC Ib Molecule in a Nude Rat Model

[Preventive Effect of Poria Cocos on Acute Rejection of Renal Transplantation in Rats].

Immunosuppressive effect and mechanism of Triptolide on skin allografts in mice